Condition
Fallopian Tube Carcinosarcoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Fallopian Tube Carcinosarcoma clinical trials that are recruiting, in United States. By phase: Phase 2 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Using a dendritic cell vaccine to treat advanced ovarian cancer
This study is testing a new vaccine made from patients' own white blood cells to see if it can help people with advanced ovarian cancer live longer and stay cancer-free compared to a placebo.
-
Combining APL-2 with Pembrolizumab and Bevacizumab for Recurrent Ovarian Cancer
This study is testing if a new treatment combining APL-2 with pembrolizumab and bevacizumab can help people with recurrent ovarian cancer feel better and live longer compared to just using bevacizumab alone.
Related topics
Quick answers
How many Fallopian Tube Carcinosarcoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.